350 related articles for article (PubMed ID: 34886175)
1. Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia.
Alhazmi A; Alamer E; Abdelwahab S; Khamjan N; Hamami A; Haddad M; Darraj M; Hashem AM; Algaissi A
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886175
[TBL] [Abstract][Full Text] [Related]
2. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia.
Alharbi NK; Alghnam S; Algaissi A; Albalawi H; Alenazi MW; Albargawi AM; Alharbi AG; Alhazmi A; Al Qarni A; Alfarhan A; Zowawi HM; Alhatmi H; Alghamdi J; Alroqi F; Batarfi K; Arabi YM; Hashem AM; Bosaeed M; Aldibasi O
J Infect Public Health; 2021 Jul; 14(7):832-838. PubMed ID: 34118732
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia.
Mahallawi WH; Alsarani MA; Aljohani RH; Alluhaibi AA; Alamri TH; Ibrahim NA; Mahallawi KH; Khabourd OF
Ann Saudi Med; 2022; 42(2):69-74. PubMed ID: 35380058
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia.
Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S
Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia.
Alosaimi MF; Alhetheel A; Aleisa KA; Altwerki AA; Alenezy NM; Almutairi EM; Alothaim LO; Khalid AMA; Alayed KM; Almazyad MA; BinMoammar TA; Alshobaili FA; Al-Shahrani FS; Alsubaie S; Hasanato RM
Saudi Med J; 2021 Aug; 42(8):853-861. PubMed ID: 34344809
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
Alhabbab RY; Alsaieedi A; Algaissi A; Almahboub S; Al-Raddadi RM; Shabouni OI; Alhabbab R; Alfaraj AA; Alamri SS; Aljehani ND; Abdulal RH; Alfaleh MA; Abujamel TS; Alkayyal AA; Mahmoud AB; Abuzenadah AM; Hashem AM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372618
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
[TBL] [Abstract][Full Text] [Related]
9. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
[TBL] [Abstract][Full Text] [Related]
10. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
Alserehi HA; Alqunaibet AM; Al-Tawfiq JA; Alharbi NK; Alshukairi AN; Alanazi KH; Bin Saleh GM; Alshehri AM; Almasoud A; Hashem AM; Alruwaily AR; Alaswad RH; Al-Mutlaq HM; Almudaiheem AA; Othman FM; Aldakeel SA; Abu Ghararah MR; Jokhdar HA; Algwizani AR; Almudarra SS; Albarrag AM
Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115273. PubMed ID: 33296851
[TBL] [Abstract][Full Text] [Related]
14. High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia.
Almudarra S; Kamel S; Saleh E; Alaswad R; Alruwaily A; Almowald S; Alqunaibet AM; Almudiaheem A; Almutlaq H; Alserehi H; Almalki S; Bahlaq MA; Alsahafi AJ; Alsaif F; Khojah AT; Al-Tawfiq JA; Asiri SI; Assiri A; Jokhdar H
Infection; 2022 Jun; 50(3):643-649. PubMed ID: 34881415
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
[TBL] [Abstract][Full Text] [Related]
17. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study.
To KK; Cheng VC; Cai JP; Chan KH; Chen LL; Wong LH; Choi CY; Fong CH; Ng AC; Lu L; Luo CT; Situ J; Chung TW; Wong SC; Kwan GS; Sridhar S; Chan JF; Fan CY; Chuang VWM; Kok KH; Hung IF; Yuen KY
Lancet Microbe; 2020 Jul; 1(3):e111-e118. PubMed ID: 33230504
[TBL] [Abstract][Full Text] [Related]
20. Assessment of SARS-CoV-2 Anti-Spike IgG Antibody in Women and Children in Madinah, Saudi Arabia: A Single-Center Study.
Mahallawi WH; Ibrahim NA; Aljohani AS; Shaikh EA; Nafe RH; Khan AM; Mumena WA
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]